Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 14.45 INR
Change Today +0.68 / 4.94%
Volume 237.0
As of 6:00 AM 04/30/15 All times are local (Market data is delayed by at least 15 minutes).

pharmasia ltd (PHRM) Snapshot

Open
14.45
Previous Close
13.77
Day High
14.45
Day Low
13.50
52 Week High
11/5/14 - 22.45
52 Week Low
05/5/14 - 7.00
Market Cap
98.6M
Average Volume 10 Days
433.4
EPS TTM
0.52
Shares Outstanding
6.8M
EX-Date
10/7/94
P/E TM
27.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for PHARMASIA LTD (PHRM)

Related News

No related news articles were found.

pharmasia ltd (PHRM) Related Businessweek News

No Related Businessweek News Found

pharmasia ltd (PHRM) Details

Phaarmasia Limited manufactures and sells pharmaceutical products and bulk drugs primarily in India. The company offers formulations, cosmetics and oral contraceptive pills. It also provides skin/face creams and tooth paste. The company was incorporated in 1981 and is based in Hyderabad, India.

Founded in 1981

pharmasia ltd (PHRM) Top Compensated Officers

Managing Director and Executive Director
Total Annual Compensation: --
Whole-Time Director, Member of Audit Committe...
Total Annual Compensation: 540.0K
Compensation as of Fiscal Year 2013.

pharmasia ltd (PHRM) Key Developments

Phaarmasia Limited Appoints Rashmi V Sapte as Additional Director

Phaarmasia Ltd. announced that the Board of Directors of the company at its meeting held on February 14, 2015, has appointed Mrs. Rashmi V Sapte as additional director of the company with effect from February 14, 2015.

Phaarmasia Limited Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

Phaarmasia Limited reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported net sales/income from operations (excluding Branch transfer, excise duty) of INR 30.214 million compared to INR 23.591 million a year ago. Profit from operations before other income was INR 0.407 million compared to loss from operations before other income of INR 1.088 million a year ago. Profit from ordinary activities before tax was INR 0.363 million compared to loss from ordinary activities before tax of INR 1.089 million a year ago. Net profit for the period was INR 0.254 million compared to net loss for the period of INR 1.089 million a year ago. Basic and diluted earnings per share were INR 0.0372. For the nine months, the company reported net sales/income from operations (excluding Branch transfer, excise duty) of INR 87.774 million compared to INR 121.075 million a year ago. Profit from operations before other income was INR 1.889 million compared to INR 0.973 million a year ago. Profit from ordinary activities before tax was INR 1.759 million compared to INR 0.929 million a year ago. Net profit for the period was INR 1.191 million compared to INR 0.743 million a year ago. Basic and diluted earnings per share were INR 0.1745 compared to INR 0.1088 a year ago.

Phaarmasia Limited, Board Meeting, Feb 14, 2015

Phaarmasia Limited, Board Meeting, Feb 14, 2015. Agenda: To consider the unaudited standalone earnings results for the third quarter and nine months ended December 31, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PHRM:IN 14.45 INR +0.68

PHRM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PHRM.
View Industry Companies
 

Industry Analysis

PHRM

Industry Average

Valuation PHRM Industry Range
Price/Earnings 24.4x
Price/Sales 0.5x
Price/Book 1.3x
Price/Cash Flow 13.4x
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMASIA LTD, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.